BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23861973)

  • 41. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
    Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
    Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
    PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide].
    Gu SY; Chen HY; Dai HM; Li XY; Zhang ZZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):828-833. PubMed ID: 29260515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.
    Zhang H; Su X; Guo L; Zhong L; Li W; Yue Z; Wang X; Mu Y; Li X; Li R; Wang Z
    Int J Med Sci; 2014; 11(12):1262-9. PubMed ID: 25317073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
    Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
    Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
    Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S
    Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.
    Guilbert C; Annis MG; Dong Z; Siegel PM; Miller WH; Mann KK
    PLoS One; 2013; 8(12):e85995. PubMed ID: 24392034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Synergistic Inhibitory Effect of Arsenic Trioxide Combined with Itraconazole on Hedgehog Pathway of Multiple Myeloma NCI-H929 Cells].
    Huang XB; Shi Y; Wang CS; Wang XD; Cheng J; Che FF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1459-1465. PubMed ID: 27784375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
    Ding D; Lim KS; Eberhart CG
    Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic trioxide exerts a double effect on osteoblast growth in vitro.
    Xu WX; Liu Y; Liu SZ; Zhang Y; Qiao GF; Yan J
    Environ Toxicol Pharmacol; 2014 Sep; 38(2):412-9. PubMed ID: 25128771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis.
    Liu Y; Yue J; Ren Z; He M; Wang A; Xie J; Li T; Liu G; He X; Ge S; Yuan Y; Yang L
    Toxicol Appl Pharmacol; 2024 Jan; 482():116798. PubMed ID: 38160894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
    Zhou XJ; Zhou YH; Chen XH; Qian WB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
    Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
    Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.
    Lee PC; Kakadiya R; Su TL; Lee TC
    Neoplasia; 2010 May; 12(5):376-87. PubMed ID: 20454509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
    Doudican NA; Wen SY; Mazumder A; Orlow SJ
    Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
    Lu J; Jin J
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8.
    Park WH; Kim SH
    Mol Biol Rep; 2012 Apr; 39(4):4311-8. PubMed ID: 21779797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
    Li X; Ding X; Adrian TE
    Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.